A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
The Schlumberger-Doll Research Center (SDR) is gathering academia, incubators, CVCs and industry players working on energy and decarbonization.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.